Gene: ANXA2

302
ANX2|ANX2L4|CAL1H|HEL-S-270|LIP2|LPC2|LPC2D|P36|PAP-IV
annexin A2
protein-coding
15q22.2
Ensembl:ENSG00000182718 MIM:151740 Vega:OTTHUMG00000132763 UniprotKB:P07355
NC_000015.10
PubMed
ND
1   
NA (AD)  NA (ND)   (Frontal_Cortex)
3.260e-1 (AD)  7.740e-1 (ND)

DNA Methylation

Probe Locus(GRCh37) Gene Region p-val Trait PubMed ID
cg00930615chr15:60690667ANXA2Promoter6.762e-5Alcohol use disorders26763658

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
CLIC10.909
S100A110.907
DRAM10.897
TAGLN20.897
PLP20.896
IL1R10.895
TIMP10.887
MYL12A0.885
S100A100.882
CASP40.881

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
NEUROD6-0.608
MARCH4-0.592
SLC7A4-0.577
ABCC12-0.577
EXTL1-0.574
BCL11A-0.557
CALHM1-0.555
LRTM2-0.55
MYADML2-0.549
KCNIP3-0.548

Drugs/Compounds

ID Drug Name Drug Type CAS Num Status Role
DB00031TenecteplaseBiotechDrug191588-94-0ApprovedTarget
DB06245LanoteplaseBiotechDrug171870-23-8InvestigationalTarget
DB11638ArtenimolSmall Molecule71939-50-9Approved|InvestigationalTarget
ID Drug Name Action PubMed
C0700461,2-dioleoyloxy-3-(trimethylammonium)propane"[Cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of ANXA2 mRNA"22129739
C1111182',3,3',4',5-pentachloro-4-hydroxybiphenyl"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of ANXA2 mRNA"19114083
C0787652,3,5-(triglutathion-S-yl)hydroquinone"2,3,5-(triglutathion-S-yl)hydroquinone results in increased expression of ANXA2 mRNA"14587099
C0294972,3-bis(3'-hydroxybenzyl)butyrolactone"[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANXA2 mRNA"19167446
C0630022,3-dimethoxy-1,4-naphthoquinone"2,3-dimethoxy-1,4-naphthoquinone results in increased expression of ANXA2 mRNA"17547211
C0235142,6-dinitrotoluene"2,6-dinitrotoluene results in increased expression of ANXA2 mRNA"20406850
C0303702-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in increased expression of ANXA2 mRNA"20206263
C0194992-nitrofluorene2-nitrofluorene results in increased expression of ANXA2 mRNA14600272
C0230353,4,5,3',4'-pentachlorobiphenyl"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of ANXA2 mRNA"20959002|2319667
C0179063-dinitrobenzene3-dinitrobenzene results in increased expression of ANXA2 mRNA21983209
C0095054,4'-diaminodiphenylmethane"4,4'-diaminodiphenylmethane results in increased expression of ANXA2 mRNA"18648102
C0095054,4'-diaminodiphenylmethane"4,4'-diaminodiphenylmethane results in increased expression of ANXA2 mRNA"25380136
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA"27188386
C0165834-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of ANXA2 mRNA14600272
C0293704-toluidine4-toluidine results in increased expression of ANXA2 mRNA27638505
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA"27188386
D000082AcetaminophenAcetaminophen results in increased expression of ANXA2 mRNA24126418
D016604Aflatoxin B1Aflatoxin B1 results in increased expression of ANXA2 mRNA21813463
C430898AGN 194204AGN 194204 results in decreased expression of ANXA2 mRNA16339527
C103303alitretinoinalitretinoin results in decreased expression of ANXA2 protein28886987
D000517alpha-Chlorohydrinalpha-Chlorohydrin results in decreased expression of ANXA2 mRNA28522335
D000517alpha-Chlorohydrinalpha-Chlorohydrin results in increased expression of ANXA2 protein26072098
D000643Ammonium ChlorideAmmonium Chloride affects the expression of ANXA2 mRNA16483693
C059765amphotericin B, deoxycholate drug combination"amphotericin B, deoxycholate drug combination results in increased expression of ANXA2 mRNA"22863853
C023650anilineaniline results in increased expression of ANXA2 mRNA22016648
D001151ArsenicArsenic affects the expression of ANXA2 mRNA18414638
C006632arsenic trioxideANXA2 protein results in decreased susceptibility to arsenic trioxide20707922
C006632arsenic trioxidearsenic trioxide affects the localization of and results in decreased expression of ANXA2 protein12165291
C006632arsenic trioxidearsenic trioxide results in decreased expression of and results in increased degradation of ANXA2 mRNA12165291
C006632arsenic trioxidearsenic trioxide results in decreased expression of ANXA2 mRNA19642359|2122373
C006632arsenic trioxidearsenic trioxide results in decreased expression of ANXA2 protein19642359|1978137
C006632arsenic trioxidearsenic trioxide results in increased expression of ANXA2 mRNA17547211
D001194AsbestosAsbestos affects the expression of ANXA2 mRNA20682992
C487081belinostatbelinostat results in increased expression of ANXA2 mRNA26272509
C487081belinostat"[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA"27188386
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of ANXA2 mRNA19770486|2590861
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of ANXA2 mRNA22228805
D004958Estradiol[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of ANXA2 mRNA20823114
D004958EstradiolEstradiol promotes the reaction [Progesterone results in increased expression of ANXA2 protein]17446234
C006780bisphenol Abisphenol A results in decreased expression of ANXA2 mRNA25047013|2927551
C006780bisphenol Abisphenol A results in increased expression of ANXA2 mRNA15223131
C006780bisphenol Abisphenol A results in increased expression of ANXA2 mRNA26063408
C006780bisphenol Abisphenol A results in increased expression of ANXA2 mRNA25181051
C006780bisphenol Abisphenol A results in increased expression of ANXA2 protein22649256
D001761BleomycinBleomycin results in decreased expression of ANXA2 protein25933445
C515564bromovaninbromovanin results in increased expression of ANXA2 protein21419150
D002104CadmiumCadmium results in increased expression of ANXA2 mRNA17547211|2437683
D019256Cadmium ChlorideCadmium Chloride results in increased expression of ANXA2 mRNA17547211
D019256Cadmium ChlorideCadmium Chloride affects the expression of ANXA2 mRNA22110744
D002118CalciumANXA2 protein binds to Calcium18508775
D002251Carbon TetrachlorideCarbon Tetrachloride results in increased expression of ANXA2 mRNA27339419
C010063carbonyl sulfidecarbonyl sulfide results in increased expression of ANXA2 mRNA19395590
D002392CatechinCatechin results in increased expression of ANXA2 mRNA15465739
D002713ChlorineChlorine results in increased expression of ANXA2 mRNA18636392
D002713Chlorine[Ozone co-treated with Chlorine] results in decreased expression of ANXA2 mRNA18636392
D002725ChloroformChloroform results in increased expression of ANXA2 mRNA21813463
D020245p-Chloromercuribenzoic Acid"[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA"27188386
D020245p-Chloromercuribenzoic Acidp-Chloromercuribenzoic Acid results in increased expression of ANXA2 mRNA26272509
C100187chloropicrinchloropicrin results in increased expression of ANXA2 mRNA26352163
D002784Cholesterol"[Cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of ANXA2 mRNA"22129739
D002794Choline[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ANXA2 mRNA20938992
D002857ChromiumChromium results in increased expression of ANXA2 mRNA17547211
D002858Chromium AlloysChromium Alloys results in increased expression of ANXA2 protein20349518
C019304ciprofibrateciprofibrate results in increased expression of ANXA2 mRNA12771043
D002994ClofibrateClofibrate results in increased expression of ANXA2 mRNA17585979
D002995Clofibric AcidClofibric Acid affects the expression of ANXA2 mRNA17602206
C018021cobaltous chloridecobaltous chloride results in increased expression of ANXA2 mRNA24386269
C018021cobaltous chloridecobaltous chloride results in increased expression of ANXA2 protein24386269
D019327Copper SulfateCopper Sulfate results in increased expression of ANXA2 mRNA19549813
D003375Coumestrol"[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANXA2 mRNA"19167446
C030973cupric oxidecupric oxide results in decreased phosphorylation of ANXA2 protein25470785
D003471CuprizoneCuprizone results in increased expression of ANXA2 mRNA26577399
C057862cyanoginosin LRcyanoginosin LR results in increased expression of ANXA2 mRNA17654400
D016572CyclosporineCyclosporine results in decreased expression of ANXA2 mRNA22147139
D003561CytarabineCytarabine results in decreased expression of ANXA2 mRNA21198554
D003561CytarabineCytarabine results in increased expression of ANXA2 mRNA12165291
D003630DaunorubicinDaunorubicin results in decreased expression of ANXA2 mRNA21223737
D003630DaunorubicinDaunorubicin results in decreased expression of ANXA2 protein21223737
C014347decitabine[decitabine co-treated with vorinostat] affects the expression of ANXA2 mRNA17330099
C014347decitabine[trichostatin A co-treated with decitabine] results in increased expression of ANXA2 protein19294695
D003703DemecolcineDemecolcine results in increased expression of ANXA2 mRNA23649840
D003994Bucladesine[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of ANXA2 mRNA20823114
D004006DichlorvosDichlorvos results in increased expression of ANXA2 mRNA21813463
C000944dicrotophosdicrotophos results in decreased expression of ANXA2 mRNA28302478
C036042dicyclohexyl phthalatedicyclohexyl phthalate affects the expression of ANXA2 mRNA26924002
D004041Dietary FatsDietary Fats affects the expression of ANXA2 mRNA19680557
D004041Dietary FatsDietary Fats results in increased expression of ANXA2 mRNA18042831|1903023
D004041Dietary FatsNEIL1 affects the reaction [Dietary Fats results in increased expression of ANXA2 mRNA]21285402
D004041Dietary Fatsrimonabant inhibits the reaction [Dietary Fats results in increased expression of ANXA2 mRNA]19030233
D004052Diethylnitrosamine[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ANXA2 mRNA24535843
D004052DiethylnitrosamineDiethylnitrosamine results in increased expression of ANXA2 mRNA12771043|2453584
D004052Diethylnitrosamine[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ANXA2 mRNA28943392
D004052DiethylnitrosamineDiethylnitrosamine results in increased expression of ANXA2 mRNA19638242|2181346
C039060dihydroartemisinindihydroartemisinin analog binds to ANXA2 protein26340163
D002117CalcitriolCalcitriol results in increased expression of ANXA2 mRNA21592394
D002117Calcitriol[Testosterone co-treated with Calcitriol] results in increased expression of ANXA2 mRNA21592394
D0151279,10-Dimethyl-1,2-benzanthracene"[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of ANXA2 protein"22248470
D004128DimethylnitrosamineDimethylnitrosamine results in increased expression of ANXA2 mRNA17547211
D004128DimethylnitrosamineDimethylnitrosamine results in increased expression of ANXA2 mRNA14600272|2538013
C024629dimethyl phthalatedimethyl phthalate results in decreased expression of ANXA2 mRNA26924002
D004137DinitrochlorobenzeneDinitrochlorobenzene results in increased expression of ANXA2 mRNA16314067
D004237DiuronDiuron results in decreased expression of ANXA2 mRNA21551480
D004317DoxorubicinDoxorubicin results in increased expression of ANXA2 mRNA22016648
C118739entinostatentinostat results in increased expression of ANXA2 mRNA26272509|2718838
C118739entinostat"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA"27188386
D004791Enzyme Inhibitors[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ANXA2 protein23301498
D004997Ethinyl EstradiolEthinyl Estradiol affects the expression of ANXA2 mRNA17555576
D004997Ethinyl EstradiolEthinyl Estradiol results in increased expression of ANXA2 mRNA17942748
D004997Ethinyl Estradiol[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ANXA2 mRNA17942748
D004997Ethinyl EstradiolEthinyl Estradiol results in increased expression of ANXA2 mRNA17557909
C540355fenamidonefenamidone results in increased expression of ANXA2 mRNA27029645
C020326ferric nitrilotriacetateferric nitrilotriacetate results in increased expression of ANXA2 mRNA10854235
D005472FluorouracilANXA2 mRNA results in decreased susceptibility to Fluorouracil15152939
D005472FluorouracilFluorouracil results in increased expression of ANXA2 mRNA15152939
D005472FluorouracilTP53 protein affects the reaction [Fluorouracil results in increased expression of ANXA2 mRNA]15152939
D005492Folic Acid[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ANXA2 mRNA20938992
C056933fumonisin B1fumonisin B1 results in increased expression of ANXA2 mRNA16221962
C039281furanfuran results in increased expression of ANXA2 mRNA15120968|2012450
D019833GenisteinGenistein results in decreased expression of ANXA2 protein22649256
D005839GentamicinsGentamicins results in increased expression of ANXA2 mRNA22061828
C010974glyphosateglyphosate results in increased expression of ANXA2 protein20045496
D006118GriseofulvinGriseofulvin results in increased expression of ANXA2 mRNA12735108
D017313FenretinideFenretinide results in decreased expression of ANXA2 mRNA28973697
D006820Hyaluronic AcidHyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of ANXA2 protein]23178681
D006830Hydralazine[Hydralazine co-treated with Valproic Acid] results in increased expression of ANXA2 mRNA17183730
D006861Hydrogen PeroxideHyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of ANXA2 protein]23178681
D006861Hydrogen PeroxideHydrogen Peroxide results in decreased expression of ANXA2 protein23178681
D007052IbuprofenIbuprofen affects the expression of ANXA2 protein18351690
D015759Ionomycin[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of ANXA2 mRNA25613284
C051890irinotecanirinotecan results in increased expression of ANXA2 mRNA15152939
D007501IronIron deficiency results in increased expression of ANXA2 mRNA20368581
D007529Isoflavones"[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of ANXA2 protein"22248470
C410337K 7174K 7174 results in decreased expression of ANXA2 mRNA24086573
D007854LeadANXA2 protein binds to Lead23896426
D007854LeadLead results in decreased expression of ANXA2 mRNA19921347
C045463leflunomideleflunomide results in decreased expression of ANXA2 mRNA24136188
D064704LevofloxacinLevofloxacin results in decreased expression of ANXA2 mRNA24136188
C482199lipopolysaccharide, E coli O55-B5"lipopolysaccharide, E coli O55-B5 results in decreased expression of ANXA2 mRNA"24972896
D008070LipopolysaccharidesLipopolysaccharides results in increased expression of ANXA2 mRNA27339419
D008070LipopolysaccharidesLipopolysaccharides results in decreased expression of ANXA2 mRNA25613284
D008094LithiumLithium results in decreased expression of ANXA2 protein18296634
D008095Lithocholic AcidLithocholic Acid results in increased expression of ANXA2 mRNA20359477
D008095Lithocholic AcidPregnenolone Carbonitrile inhibits the reaction [Lithocholic Acid results in increased expression of ANXA2 mRNA]20359477
C013099mancozebmancozeb results in decreased expression of ANXA2 protein21375462
D008345ManganeseManganese results in increased expression of ANXA2 mRNA18284614
D017258Medroxyprogesterone Acetate[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of ANXA2 mRNA20823114
C042720mercuric bromidemercuric bromide results in increased expression of ANXA2 mRNA26272509
C042720mercuric bromide"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA"27188386
D008628MercuryMercury results in increased expression of ANXA2 mRNA17547211
D008701MethapyrileneMethapyrilene results in increased expression of ANXA2 mRNA15120968|2181346
D008715Methionine[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ANXA2 mRNA20938992
C004925methylmercuric chloridemethylmercuric chloride results in increased expression of ANXA2 mRNA28001369
D0156551-Methyl-4-phenylpyridinium1-Methyl-4-phenylpyridinium affects the expression of ANXA2 mRNA12710931
D0156551-Methyl-4-phenylpyridinium1-Methyl-4-phenylpyridinium results in increased expression of ANXA2 protein24675778
D0156551-Methyl-4-phenylpyridinium1-Methyl-4-phenylpyridinium results in increased expression of ANXA2 protein26558463
C517284monomethyl phthalatemonomethyl phthalate affects the expression of ANXA2 mRNA26924002
D037742Nanotubes, Carbon"Nanotubes, Carbon affects the expression of ANXA2 protein"21135415
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in decreased expression of ANXA2 mRNA"25620056
D037742Nanotubes, Carbon"Nanotubes, Carbon results in decreased secretion of ANXA2 protein"25598225
D037742Nanotubes, Carbon"Nanotubes, Carbon results in increased expression of ANXA2 mRNA"25554681
D0150581-Naphthylisothiocyanate1-Naphthylisothiocyanate results in increased expression of ANXA2 mRNA25380136
D009532NickelNickel results in increased expression of ANXA2 mRNA25583101
C022838nickel chloridenickel chloride results in increased expression of ANXA2 protein11250053
C022838nickel chloridenickel chloride affects the expression of ANXA2 mRNA22110744
C029938nickel sulfatenickel sulfate results in increased expression of ANXA2 mRNA16314067
D009585Nitrogen DioxideNitrogen Dioxide results in increased expression of ANXA2 protein9165304
C014707nitrosobenzylmethylaminenitrosobenzylmethylamine results in increased expression of ANXA2 mRNA17616710
C025589ochratoxin Aochratoxin A results in increased expression of ANXA2 mRNA12700408|1841718
C484027oligofectamineoligofectamine results in decreased expression of ANXA2 mRNA14668052
C030110oxaliplatinoxaliplatin results in increased expression of ANXA2 mRNA15152939
D010100OxygenOxygen deficiency affects the expression of ANXA2 mRNA17193925
D010126Ozone[Ozone co-treated with Chlorine] results in decreased expression of ANXA2 mRNA18636392
D000073878Palm OilPalm Oil results in increased expression of ANXA2 mRNA18042831
C496932panobinostat"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA"27188386
C496932panobinostatpanobinostat results in increased expression of ANXA2 mRNA26272509
D010269ParaquatParaquat results in increased expression of ANXA2 protein24521700
D052638Particulate Matter[ANXA2 gene mutant form affects the susceptibility to Particulate Matter] which results in decreased expression of ANXA2 mRNA21222557|2122255
D010634Phenobarbital[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ANXA2 mRNA24535843
D010634PhenobarbitalNR1I3 protein affects the reaction [Phenobarbital results in increased expression of ANXA2 mRNA]19482888
D010634PhenobarbitalPhenobarbital affects the methylation of ANXA2 gene19233941
D010634PhenobarbitalPhenobarbital results in increased expression of ANXA2 mRNA19482888
D010634PhenobarbitalPhenobarbital results in increased methylation of ANXA2 promoter19482888
D010662Phenylmercuric Acetate"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA"27188386
D010662Phenylmercuric AcetatePhenylmercuric Acetate results in increased expression of ANXA2 mRNA26272509
C006253pirinixic acid[pirinixic acid co-treated with PPARA] results in increased expression of ANXA2 mRNA20813756
C006253pirinixic acidpirinixic acid results in increased expression of ANXA2 mRNA16221962|1769013
C006253pirinixic acidPPARA protein affects the reaction [pirinixic acid results in increased expression of ANXA2 mRNA]16221962
C006253pirinixic acidPPARA protein promotes the reaction [pirinixic acid results in increased expression of ANXA2 mRNA]20059764
C443641poly(propyleneimine)poly(propyleneimine) analog results in increased expression of ANXA2 mRNA16308212
D011192Potassium DichromatePotassium Dichromate results in increased expression of ANXA2 mRNA17547211
D011223PraziquantelPraziquantel results in increased expression of ANXA2 mRNA21813463
D011285Pregnenolone CarbonitrilePregnenolone Carbonitrile inhibits the reaction [Lithocholic Acid results in increased expression of ANXA2 mRNA]20359477
D011374ProgesteroneEstradiol promotes the reaction [Progesterone results in increased expression of ANXA2 protein]17446234
D011374ProgesteroneProgesterone results in increased expression of ANXA2 mRNA17446234
D011374ProgesteroneProgesterone results in increased expression of ANXA2 protein17446234
D011441PropylthiouracilPropylthiouracil results in decreased expression of ANXA2 mRNA24780913
C513428pyrachlostrobinpyrachlostrobin results in increased expression of ANXA2 mRNA27029645
D011794QuercetinQuercetin results in increased expression of ANXA2 protein15221776
D011794QuercetinQuercetin results in decreased expression of ANXA2 protein18095365
C037219quinolinequinoline analog results in increased expression of ANXA2 protein18645022
C068874raltitrexedraltitrexed results in increased expression of ANXA2 mRNA15152939
C068874raltitrexedTYMS protein inhibits the reaction [raltitrexed results in increased expression of ANXA2 mRNA]15152939
C059514resveratrolresveratrol results in increased expression of ANXA2 mRNA23750556
C059514resveratrolresveratrol results in increased expression of ANXA2 protein18089832
C089032rimonabantrimonabant affects the expression of ANXA2 mRNA19030233
C089032rimonabantrimonabant inhibits the reaction [Dietary Fats results in increased expression of ANXA2 mRNA]19030233
C089730rosiglitazonerosiglitazone affects the expression of ANXA2 mRNA19556978
C089730rosiglitazonerosiglitazone affects the expression of ANXA2 protein19556978
D012402RotenoneRotenone results in increased expression of ANXA2 mRNA22016648|2318674
D012822Silicon DioxideSilicon Dioxide analog affects the secretion of ANXA2 protein25895662
C017947sodium arsenitesodium arsenite affects the expression of ANXA2 mRNA16507464
C016104sodium bichromatesodium bichromate results in decreased expression of ANXA2 mRNA17685462
C016104sodium bichromatesodium bichromate results in decreased expression of ANXA2 mRNA22155349
C016104sodium bichromatesodium bichromate results in increased expression of ANXA2 mRNA22155349
C016104sodium bichromatesodium bichromate results in increased expression of ANXA2 mRNA25993096
D012969Sodium FluorideSodium Fluoride results in decreased expression of ANXA2 protein28918527
D012969Sodium FluorideSodium Fluoride results in increased expression of ANXA2 protein27548804
D012999SomanSoman results in increased expression of ANXA2 mRNA19281266
D010042OuabainOuabain affects the expression of ANXA2 protein17268060
D012460SulfasalazineSulfasalazine results in increased expression of ANXA2 mRNA22016648
C013698tallowtallow affects the expression of ANXA2 mRNA19680557
C061133tamibarotenetamibarotene results in decreased expression of ANXA2 mRNA15498508
D013629TamoxifenTamoxifen affects the expression of ANXA2 mRNA17555576
D013739Testosterone[Testosterone co-treated with Calcitriol] results in increased expression of ANXA2 mRNA21592394
D013739TestosteroneTestosterone results in increased expression of ANXA2 mRNA21592394
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of ANXA2 mRNA21570461
D013749Tetrachlorodibenzodioxin[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ANXA2 mRNA17942748
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of ANXA2 mRNA19770486
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of ANXA2 protein19201780
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of ANXA2 mRNA20959002|2121527
D013755Tetradecanoylphorbol AcetateTetradecanoylphorbol Acetate results in increased expression of ANXA2 protein20045496
D013755Tetradecanoylphorbol Acetate[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of ANXA2 mRNA25613284
D013792ThalidomideThalidomide results in decreased expression of ANXA2 mRNA19954599
D013792ThalidomideThalidomide results in decreased expression of ANXA2 protein19954599
D013853Thioacetamide[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ANXA2 mRNA28943392
D013853ThioacetamideThioacetamide results in increased expression of ANXA2 mRNA23411599
D013864ThioglycolatesThioglycolates results in increased expression of ANXA2 protein14504107
C009495titanium dioxidetitanium dioxide results in decreased phosphorylation of ANXA2 protein21439344
D014028Tobacco Smoke PollutionTobacco Smoke Pollution results in decreased expression of ANXA2 mRNA28065790
D014028Tobacco Smoke PollutionTobacco Smoke Pollution results in increased metabolism of ANXA2 protein23396223
D014028Tobacco Smoke PollutionTobacco Smoke Pollution results in decreased expression of ANXA2 mRNA28111298
D014212TretinoinTretinoin affects the localization of and results in decreased expression of ANXA2 protein12165291
D014212TretinoinTretinoin results in decreased expression of ANXA2 mRNA12165291|1549850
D014212TretinoinTretinoin results in decreased expression of ANXA2 protein16197459|1964235
D014212TretinoinTretinoin results in decreased expression of ANXA216757074
C012589trichostatin A"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA"27188386
C012589trichostatin A[trichostatin A co-treated with decitabine] results in increased expression of ANXA2 protein19294695
C012589trichostatin Atrichostatin A results in increased expression of ANXA2 mRNA24935251|2627250
C012589trichostatin Atrichostatin A results in increased expression of ANXA2 protein19294695
C015559trimellitic anhydridetrimellitic anhydride results in increased expression of ANXA2 mRNA19042947
C013320tris(2-butoxyethyl) phosphatetris(2-butoxyethyl) phosphate affects the expression of ANXA2 mRNA29024780
D014502Uranyl NitrateUranyl Nitrate results in increased expression of ANXA2 mRNA16316344
D014502Uranyl NitrateUranyl Nitrate results in increased expression of ANXA2 protein16316344
D014520UrethaneUrethane results in decreased expression of ANXA2 mRNA28818685
D014635Valproic Acid[Hydralazine co-treated with Valproic Acid] results in increased expression of ANXA2 mRNA17183730
D014635Valproic Acid"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA"27188386
D014635Valproic AcidValproic Acid affects the expression of ANXA2 mRNA25979313
D014635Valproic AcidValproic Acid results in increased expression of ANXA2 mRNA19101580|2317975
D014635Valproic AcidValproic Acid affects the expression of ANXA2 mRNA17292431
D014640VancomycinVancomycin results in decreased expression of ANXA2 mRNA18930951
D001335Vehicle Emissions[ANXA2 gene mutant form affects the susceptibility to Vehicle Emissions] which results in decreased expression of ANXA2 mRNA21222557|2122255
C025643vinclozolinvinclozolin affects the expression of ANXA2 mRNA19015723
C025643vinclozolinvinclozolin results in decreased expression of ANXA2 mRNA23034163
D014750VincristineVincristine results in increased expression of ANXA2 mRNA23649840
C029297vinylidene chloridevinylidene chloride results in increased expression of ANXA2 mRNA26682919
D014800VitalliumVitallium analog results in decreased expression of ANXA2 mRNA23825117
D014807Vitamin DVitamin D affects the expression of ANXA2 mRNA20368581
C111237vorinostat[decitabine co-treated with vorinostat] affects the expression of ANXA2 mRNA17330099
C111237vorinostat"[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA"27188386
C111237vorinostatvorinostat results in increased expression of ANXA2 mRNA26272509|2718838
D015032ZincZinc results in decreased expression of ANXA2 mRNA17074742
D019287Zinc SulfateZinc Sulfate affects the expression of ANXA2 protein25162517
D019287Zinc SulfateZinc Sulfate results in decreased expression of ANXA2 mRNA17074742
C088658zoledronic acidzoledronic acid results in decreased expression of ANXA2 protein28871336

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0002020protease binding-IPI22848640  
GO:0003723RNA binding-HDA22658674  
GO:0005509calcium ion binding-IEA-  
GO:0005515protein binding-IPI14522961  18799458  19724273  20706999  21044950  21886777  
22301157  24457100  25136068  25139904  26812398  26941067  
GO:0005544calcium-dependent phospholipid binding-IDA2138016  
GO:0005546phosphatidylinositol-4,5-bisphosphate binding-IMP23861394  
GO:0008092cytoskeletal protein binding-IEA-  
GO:0017137Rab GTPase binding-IEA-  
GO:0019834phospholipase A2 inhibitor activity-IDA3013422  
GO:0042802identical protein binding-IPI18799458  26812398  
GO:0044548S100 protein binding-IPI14699089  23091277  
GO:0044730bone sialoprotein binding-IEA-  
GO:0048306calcium-dependent protein binding-IPI15226301  
GO:0098641cadherin binding involved in cell-cell adhesion-HDA25468996  
GO:0098772molecular function regulator-IDA22848640  
GO ID GO Term Qualifier Evidence PubMed
GO:0001525angiogenesis-IEP11866539  
GO:0001765membrane raft assembly-IMP23861394  
GO:0001921positive regulation of receptor recycling-IDA22848640  
GO:0001934positive regulation of protein phosphorylation-IEA-  
GO:0006900vesicle budding from membrane-IMP23861394  
GO:0007589body fluid secretion-IEA-  
GO:0030199collagen fibril organization-IEA-  
GO:0031340positive regulation of vesicle fusion-IDA2138016  
GO:0032804negative regulation of low-density lipoprotein particle receptor catabolic process-IDA22848640  
GO:0035722interleukin-12-mediated signaling pathway-TAS-  
GO:0036035osteoclast development-IDA7961821  
GO:0042730fibrinolysis-IEA-  
GO:0043086negative regulation of catalytic activity-IEA-  
GO:0043312neutrophil degranulation-TAS-  
GO:0044090positive regulation of vacuole organization-IMP25139904  
GO:0044147negative regulation of development of symbiont involved in interaction with host-IMP26812398  
GO:0048146positive regulation of fibroblast proliferation-IEA-  
GO:0051290protein heterotetramerization-IDA23091277  23861394  
GO:0052362catabolism by host of symbiont protein-IMP26812398  
GO:0052405negative regulation by host of symbiont molecular function-IMP26812398  
GO:0072659protein localization to plasma membrane-IEA-  
GO:0097066response to thyroid hormone-IEA-  
GO:0098609cell-cell adhesion-IEA-  
GO:1905581positive regulation of low-density lipoprotein particle clearance-IDA22848640  
GO:1905597positive regulation of low-density lipoprotein particle receptor binding-IDA22848640  
GO:1905599positive regulation of low-density lipoprotein receptor activity-IMP22848640  
GO:1905602positive regulation of receptor-mediated endocytosis involved in cholesterol transport-IDA22848640  
GO ID GO Term Qualifier Evidence PubMed
GO:0001726ruffle-IEA-  
GO:0005576extracellular region-HDA27068509  
GO:0005576extracellular region-TAS-  
GO:0005604basement membrane-IEA-  
GO:0005615extracellular space-HDA22664934  
GO:0005634nucleus-HDA21630459  
GO:0005737cytoplasm-IDA25139904  26812398  
GO:0005765lysosomal membrane-IDA23360953  
GO:0005768endosome-IDA18767904  
GO:0005769early endosome-IEA-  
GO:0005811lipid droplet-IDA14741744  
GO:0005829cytosol-IEA-  
GO:0005886plasma membrane-IDA18799458  
GO:0005913cell-cell adherens junction-HDA25468996  
GO:0005938cell cortex-IEA-  
GO:0009986cell surface-IDA10809787  25139904  
GO:0016020membrane-HDA19946888  
GO:0016323basolateral plasma membrane-ISS-  
GO:0019897extrinsic component of plasma membrane-IEA-  
GO:0030496midbody-IDA15166316  
GO:0031902late endosome membrane-IDA23360953  
GO:0031982vesicle-HDA19190083  
GO:0035578azurophil granule lumen-TAS-  
GO:0035749myelin sheath adaxonal region-IEA-  
GO:0042383sarcolemma-IEA-  
GO:0042470melanosome-IEA-  
GO:0043220Schmidt-Lanterman incisure-IEA-  
GO:0044354macropinosome-IEA-  
GO:0045121membrane raftcolocalizes_withIDA14699089  
GO:0048471perinuclear region of cytoplasm-IEA-  
GO:0062023collagen-containing extracellular matrix-HDA27559042  
GO:0062023collagen-containing extracellular matrixcolocalizes_withISS22261194  
GO:0070062extracellular exosome-HDA19056867  19199708  20458337  21362503  23533145  
GO:0070062extracellular exosome-IDA22057634  
GO:1990667PCSK9-AnxA2 complex-IDA22848640  
KEGG ID KEGG Term
Reactome ID Reactome Term Evidence
R-HSA-109582HemostasisTAS
R-HSA-1280215Cytokine Signaling in Immune systemTAS
R-HSA-168249Innate Immune SystemTAS
R-HSA-168256Immune SystemTAS
R-HSA-397014Muscle contractionIEA
R-HSA-445355Smooth Muscle ContractionIEA
R-HSA-447115Interleukin-12 family signalingTAS
R-HSA-449147Signaling by InterleukinsTAS
R-HSA-6798695Neutrophil degranulationTAS
R-HSA-75205Dissolution of Fibrin ClotTAS
R-HSA-8950505Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulationTAS
R-HSA-9020591Interleukin-12 signalingTAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
28811900SLPI and AnxA2 expression in neoplasm-free palatine tonsils is associated with smoking habit of individuals. (2017 Sep)Quabius ESMol Clin Oncol